Quadrant Capital Group LLC 10x Genomics, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.25 Billion
  • Q1 2024

A detailed history of Quadrant Capital Group LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 95 shares of TXG stock, worth $1,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 150 36.67%
Holding current value
$1,792
Previous $8,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$36.08 - $54.3 $1,984 - $2,986
-55 Reduced 36.67%
95 $3,000
Q4 2023

Feb 08, 2024
BUY
$34.32 - $57.55 $34 - $57
1 Added 0.67%
150 $8,000
Q1 2023

May 11, 2023
SELL
$35.33 - $55.79 $2,897 - $4,574
-82 Reduced 35.5%
149 $8,000
Q4 2022

Feb 10, 2023
BUY
$24.4 - $41.3 $2,854 - $4,832
117 Added 102.63%
231 $8,000
Q3 2022

Nov 10, 2022
BUY
$28.48 - $52.59 $1,879 - $3,470
66 Added 137.5%
114 $3,000
Q2 2022

Aug 09, 2022
SELL
$36.95 - $82.41 $1,884 - $4,202
-51 Reduced 51.52%
48 $2,000
Q1 2022

May 06, 2022
BUY
$55.7 - $145.79 $55 - $145
1 Added 1.02%
99 $8,000
Q4 2021

Feb 01, 2022
BUY
$135.05 - $182.59 $4,861 - $6,573
36 Added 58.06%
98 $15,000
Q3 2021

Nov 12, 2021
BUY
$145.58 - $192.14 $582 - $768
4 Added 6.9%
62 $9,000
Q2 2021

Aug 09, 2021
SELL
$134.22 - $202.37 $5,771 - $8,701
-43 Reduced 42.57%
58 $11,000
Q1 2021

May 12, 2021
BUY
$140.25 - $196.86 $7,012 - $9,843
50 Added 98.04%
101 $18,000
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $6,449 - $8,348
51 New
51 $7,000
Q3 2020

Nov 13, 2020
SELL
$87.44 - $125.0 $13,203 - $18,875
-151 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$58.39 - $89.31 $8,816 - $13,485
151 New
151 $13,000

Others Institutions Holding TXG

# of Institutions
309
Shares Held
92M
Call Options Held
267K
Put Options Held
62.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.79B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email